Frontiers | Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
KAPAG collection – KAPAG Board + Paper
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma | Journal of Hematology & Oncology | Full Text
Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy - ScienceDirect
Biomolecules | Free Full-Text | Gangliosides: The Double-Edge Sword of Neuro-Ectodermal Derived Tumors | HTML
ASC amino acid transporter 2, defined by enzyme‐mediated activation of radical sources, enhances malignancy of GD2‐positive small‐cell lung cancer - Esaki - 2018 - Cancer Science - Wiley Online Library
Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody - ScienceDirect
Environmental Statement - MM Karton
KAPAG collection – KAPAG Board + Paper
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction - ScienceDirect
GD2 - Wikipedia
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors | Cancer Gene Therapy
Anti-GD2 antibody dinutuximab inhibits triple-negative breast tumor growth by targeting GD2+ breast cancer stem-like cells | Journal for ImmunoTherapy of Cancer
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis | Nature Medicine
FC FOODCART / GD2 / MM Frohnleiten GmbH - MM digital - Product Details
A Monoclonal Antibody to O-Acetyl-GD2 Ganglioside and Not to GD2 Shows Potent Anti-Tumor Activity without Peripheral Nervous System Cross-Reactivity | PLOS ONE
Biomolecules | Free Full-Text | Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma | HTML
Frontiers | Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Antitumor activity without on-target off-tumor toxicity of GD2–chimeric antigen receptor T cells in patients with neuroblastoma | Science Translational Medicine
GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | Journal for ImmunoTherapy of Cancer
Targeting glycosphingolipids for cancer immunotherapy
Umka Color GD2 – Umka Cardboard Mill d.o.o.
Spotlight on dinutuximab in the treatment of high-risk neuroblastoma: | BTT
STARCOLOR MIRABELL™ GD2
GD2 KONDOR | Buchmann Karton
